Acridine and quinoline dervatives as sirtuin modulators

Details for Australian Patent Application No. 2006218405 (hide)

Owner Sirtris Pharmaceuticals, Inc.

Inventors Xie, Roger; Bemis, Jean; Normington, Karl D.; Nunes, Joseph J.; Milburn, Michael; Milne, Jill

Agent Shelston IP

Pub. Number AU-A-2006218405

PCT Pub. Number WO2006/094237

Priority 60/658,711 03.03.05 US; 60/705,609 04.08.05 US

Filing date 3 March 2006

Wipo publication date 8 September 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 215/48 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/52 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 219/04 (2006.01) Heterocyclic compounds containing acridine or hydrogenated acridine ring systems

C07D 219/10 (2006.01) Heterocyclic compounds containing acridine or hydrogenated acridine ring systems

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094237 Priority application(s): WO2006/094237

21 February 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Acridine and quinoline derivatives as sirtuin modulators

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218407-Fluorescence polarization assays for acetyltransferase/deacetylase activity

2006218404-N-phenyl benzamide derivatives as sirtuin modulators